Broader access urged for affordable HIV drug
|
Access gaps remain for HIV drug lenacapavir despite
$US40-a-year price-tag, campaigners say. |
University of Tennessee professor receives grant for HIV research
HIV is the virus that eventually leads to AIDS. Modern antiretroviral therapy has been around for more than 20 years, but the research ... View article...